-+ 0.00%
-+ 0.00%
-+ 0.00%

Baird Maintains Neutral on HCA Healthcare, Lowers Price Target to $393

Benzinga·07/27/2026 11:59:04
Listen to the news
Baird analyst Michael Ha maintains HCA Healthcare (NYSE:HCA) with a Neutral and lowers the price target from $396 to $393.